Prosecution Insights
Last updated: April 19, 2026

Examiner: WHISENANT, ETHAN C

Tech Center 1700 • Art Units: 1634 1643 1683 1797

This examiner grants 70% of resolved cases

Performance Statistics

70.5%
Allow Rate
+5.5% vs TC avg
868
Total Applications
+23.2%
Interview Lift
1159
Avg Prosecution Days
Based on 855 resolved cases, 2023–2026

Rejection Statute Breakdown

4.2%
§101 Eligibility
4.9%
§102 Novelty
49.8%
§103 Obviousness
12.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17817650 Application of circIKBKB Inhibitors and Test Reagents thereof in Diagnosis, Treatment and Prognosis Kits for Breast Cancer Bone Metastasis Non-Final OA SUN YAT-SEN UNIVERSITY
17572260 Nuclease Resistant Polynucleotides and Uses Thereof Final Rejection Translate Bio, Inc.
18253115 THERAPEUTIC-OLIGONUCLEOTIDES ACTIVATED BY NUCLEASES Non-Final OA Frank J. HERNANDEZ
17887752 DETECTION METHOD USING EUKARYOTIC CELLS Non-Final OA GENEOSCOPY, INC.
17516303 METHODS AND SYSTEMS FOR SAMPLE PROCESSING OR ANALYSIS Non-Final OA ReadCoor, LLC
17366643 METHOD FOR THE MONITORING OF MODIFIED NUCLEASES INDUCED-GENE EDITING EVENTS BY MOLECULAR COMBING Non-Final OA GENOMIC VISION SA
17058167 DIRECT NUCLEIC ACID SEQUENCING METHOD Final Rejection New York Institute of Technology

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month